Volume and probable stock direction | TCRT Message Board Posts


Alaunos Therapeutics, Inc.

  TCRT website

TCRT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  120700 of 120929  at  11/30/2022 1:55:27 PM  by

luckijack


 In response to msg 120689 by  Mabel
view thread

Re: Volume and probable stock direction

 I for one would like them to sell, even at that $2.5-$3.0 per share, if they sell to a quality pharma that has resources to put into this endeavor.   TCRT limps along with insufficient money to move anything quickly, and I think the anti-viral t-CRT has great promise -- I'd like to see it move forward quickly.  
 
That said, I do believe if the next few patients show decent/good results, and I'm talking 5-8 patients (ten total), this stock will go over that $3 bucks, and potentially the company might sell then for double that or more.   250 million shares, at $3, is just $750 million which nothing for a pharma to shell out, this without TCRT showing definitively stellar results but just good results on say 40% of patients.     And it would be real helpful to reduce the schedule from that 26 day turn-a-round to 10 days -- this is the kinda progress where you need good technical resources and money.
 
jack 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
120703 Re: Volume and probable stock direction///luckijack pharmionphil 1 11/30/2022 3:59:50 PM




Financial Market Data provided by
.
Loading...